APOB and Alzheimer disease: To test whether hypercholesterolaemia facilitates the progress of MCI to AD, the plasma cholesterol levels, cognitive and locomotor status, and the pathological signs of such progress were monitored in naïve apoB100/LDLR-/- mice at 3 and 18 months of age.